Source approach

Dates need context.

This is the planned approach for the public calendar. The calendar is still in preparation, and this website does not publish catalyst records.

Start with the underlying source

The project is designed around company investor-relations announcements, FDA materials, SEC filings, and ClinicalTrials.gov records. Secondary reporting can point to an event; the underlying source should support the entry.

Keep the source's level of precision

An announced day, a month, and a quarter are different kinds of timing. A broad window should stay broad until a source supports a more specific date. Expected timing can change.

Explain the event in plain English

An entry should identify the company, treatment, and milestone, then explain what the event means. Labels such as “FDA decision” are easier to read than unexplained specialist abbreviations.

Make uncertainty visible

The intended calendar distinguishes tentative timing and unverified material from reviewed information. Automated research can assist with finding and summarizing material, but its output is not proof that a date or claim is correct. The source remains essential.

Stay within the evidence

The project does not aim to predict treatment outcomes or share-price movements. This informational site is not a research service, a trading tool, or a source of medical guidance.

Questions or corrections

Send source suggestions or questions to contact@biotechtracker.dev. Please include a public source link when it helps explain your message.